Worg is fully committed to exploit the potential of our Apitope technology for the benefits of patients by exploring its application in other indications such as Myocarditis, Rheumatoid Arthritis, by taking advantage of the specificity in Apitope peptide selection, and by exploring the treatments for undesired immune responses, e.g. anti-drug antibodies against biologic therapeutics.